Harrow (HROW) was downgraded by Zacks Research from "hold" to "strong sell".
Harrow (HROW) had its price target lowered by Cantor Fitzgerald from $94.00 to $91.00. They now have an "overweight" rating on the stock.
Harrow (HROW) had its price target raised by HC Wainwright from $69.00 to $70.00. They now have a "buy" rating on the stock.
Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference [Yahoo! Finance]
Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference